Transdermal Drug Delivery Systems Market Growing at 4.9% CAGR, Set to Reach USD 87.32 Billion By 2030, Exclusive Report

How big is the transdermal drug delivery systems market?

As per the report published by Allied Market Research, the global transdermal drug delivery systems market generated $52.47 billion in 2020, and is expected to reach $87.32 billion by 2030, growing at a CAGR of 4.9% from 2021 to 2030.

Major Factors Driving the Growth of  Market:

• Increasing prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, cardiovascular disease, and diabetes is on the rise globally. Transdermal drug delivery systems can offer a number of advantages over traditional oral and injectable drug delivery methods for the treatment of chronic diseases, such as sustained drug release, reduced side effects, and improved patient convenience.
• Growing demand for non-invasive drug delivery: There is a growing demand for non-invasive drug delivery methods, as they are more convenient and less painful for patients. Transdermal drug delivery systems are a non-invasive drug delivery method that can be used to deliver a wide range of drugs, including small molecules, peptides, and proteins.
• Rising acceptance of transdermal drug delivery systems: Transdermal drug delivery systems are becoming increasingly accepted by patients and healthcare professionals. This is due to the many advantages of transdermal drug delivery systems, such as sustained drug release, reduced side effects, and improved patient convenience.
• Technological advancements in transdermal drug delivery systems: Technological advancements are leading to the development of new and improved transdermal drug delivery systems. For example, researchers are developing new transdermal patches that can deliver drugs more efficiently and effectively.

Request Sample Copy of Report: 

https://www.alliedmarketresearch.com/request-sample/485

Key Takeaways:

• Motion sickness segment is estimated to manifest the highest CAGR of 6.3% from 2021 to 2030.
• Asia-Pacific is anticipated to portray the highest CAGR of 6.1% during the forecast period.
• The rise in global population has significantly increased the demand for geriatric medicines.

Covid-19 scenario:

• The Covid-19 pandemic negatively impacted the market due to prolonged lockdown. However, the pandemic increased the importance of government healthcare facilities and healthcare spending across the globe.
• Decrease in number of Covid-19 cases led to reopening of transdermal drug delivery system research facilities, which will help the market get back on track.

Market Segmentation:

Type of drug: The transdermal drug delivery systems market can be segmented based on the type of drug delivered. Some of the major drug types delivered using transdermal drug delivery systems include:

• • Small molecules: Small molecules are small drug molecules that can easily penetrate the skin. Examples of small molecules delivered using transdermal drug delivery systems include nicotine, nitroglycerin, and fentanyl.
  • Peptides: Peptides are short chains of amino acids. Peptides are larger and more complex than small molecules, but they can still be delivered using transdermal drug delivery systems. Examples of peptides delivered using transdermal drug delivery systems include insulin and growth hormone.
  • Proteins: Proteins are large and complex molecules. Proteins are the most challenging type of drug to deliver using transdermal drug delivery systems, but there has been significant progress in recent years. Examples of proteins that are being delivered using transdermal drug delivery systems include interferon and erythropoietin.

Route of administration: The transdermal drug delivery systems market can also be segmented based on the route of administration. Some of the major routes of administration for transdermal drug delivery systems include:

• • Patches: Transdermal patches are the most common type of transdermal drug delivery system. Transdermal patches are thin, adhesive patches that are applied to the skin. The drug is released from the patch into the skin over a period of time.
  • Films: Transdermal films are similar to transdermal patches, but they are thinner and more flexible. Transdermal films are often used to deliver drugs to sensitive areas of the skin, such as the face and neck.
  • Gels: Transdermal gels are semi-solid formulations that are applied to the skin. The drug is released from the gel into the skin over a period of time.

Application: The transdermal drug delivery systems market can also be segmented based on the application. Some of the major applications for transdermal drug delivery systems include:

• • Pain management: Transdermal drug delivery systems are widely used for pain management. For example, transdermal patches are used to deliver opioids, such as fentanyl, for pain relief.
  • Smoking cessation: Transdermal nicotine patches are used to help people quit smoking. The nicotine patch delivers a small amount of nicotine into the body over a period of time, which helps to reduce cravings and withdrawal symptoms.
  • Heart disease: Transdermal nitroglycerin patches are used to treat angina pectoris, a type of chest pain caused by coronary artery disease. The nitroglycerin patch delivers a small amount of nitroglycerin into the body over a period of time, which helps to widen the blood vessels and improve blood flow to the heart.

End-user: The transdermal drug delivery systems market can also be segmented based on the end-user. Some of the major end-user segments include:

• • Hospitals: Hospitals are the largest users of transdermal drug delivery systems. Hospitals use transdermal drug delivery systems to treat a wide range of patients, including those with pain, smoking cessation, and heart disease.
  • Clinics: Clinics also use transdermal drug delivery systems to treat a variety of patients. For example, clinics use transdermal nicotine patches to help people quit smoking.
  • Home healthcare: Transdermal drug delivery systems are also used in home healthcare settings. For example, transdermal patches are used to deliver pain medication and nicotine replacement therapy to patients at home.

By Region Analysis:

• Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
• LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
• North America  (U.S, Canada, Mexico)
• Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)

Request for Customization:

https://www.alliedmarketresearch.com/request-for-customization/485

Regional Growth Dynamics:

The global transdermal drug delivery systems market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion’s share in 2020, accounting for more than two-fifths of the market. However, market across Asia-Pacific is anticipated to portray the highest CAGR of 6.1% during the forecast period.

Competitive Landscape:

• Viatris Inc.
• Bayer AG
• Boehringer Ingelheim GmbH
• Endo International plc
• GlaxoSmithKline plc.
• Johnson & Johnson
• Novartis AG
• Purdue Pharma L.P.
• Altaris
• Hisamitsu Pharmaceutical Co. Inc.

Recent developments:

• New transdermal patches for the treatment of pain and inflammation: Several companies are developing new transdermal patches for the treatment of pain and inflammation. For example, in 2023, Grünenthal launched a new transdermal patch called Qutenza that is used to treat moderate to severe osteoarthritis pain. Qutenza delivers capsaicin, a natural substance that reduces pain and inflammation, into the skin over a period of 84 hours.
• Transdermal patches for the delivery of vaccines: Transdermal patches are also being developed for the delivery of vaccines. For example, in 2023, Vaxxas began Phase 1 clinical trials of a transdermal patch vaccine for COVID-19. The Vaxxas patch uses microneedles to deliver the vaccine into the skin, which is a more efficient and effective way to deliver vaccines than traditional injections.

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/485

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Why Choose Allied Market Research?

Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

Schedule a call with our analyst

Browse more latest healthcare reports:

Foam Dressings Market by Material (Polyurethane, Silicone), by Application (Chronic Wounds, Acute Wounds), by End User (Hospitals, Home Healthcare, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Advanced Wound Care Market by Product (Infection Management, Exudate Management, Active Wound Care, and Therapy Devices), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals and Community Health Service Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030

Pharmacy Automation System Market by Product Type (Automated Medication Dispensing System, Automated Storage & Retrieval System, Automated Packaging & Labeling System, Tabletop Tablet Counters, and Automated Compounding Devices), and End User (Retail Pharmacy, Hospital Pharmacy, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Private Nursing Services Market by Service Type (Retirement Communities, Group Care Homes, Nursing Care Facilities, Home Healthcare Provider), by Gender (Female, Male): Global Opportunity Analysis and Industry Forecast, 2021-2031

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285                                                          
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter